Recursion Pharmaceuticals has been granted a patent for compounds of Formula (I) and Formula (II) for treating diseases. The patent includes pharmaceutical compositions and methods for treatment. GlobalData’s report on Recursion Pharmaceuticals gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Recursion Pharmaceuticals, Vehicle driver physiological monitoring was a key innovation area identified from patents. Recursion Pharmaceuticals's grant share as of April 2024 was 36%. Grant share is based on the ratio of number of grants to total number of patents.
A recently granted patent (Publication Number: US11919868B2) discloses a compound of Formula (I) and its various stereoisomers, tautomers, and pharmaceutically acceptable salts. The patent also covers specific compounds represented by Formulas (Ia) to (If) and Formula (II) along with their variations. Additionally, the patent includes a pharmaceutical composition containing the compound as well as a method for making the compound using specific schemes outlined in the patent.
Furthermore, the patent describes a method for treating Clostridium difficile (C. difficile) infection by administering the disclosed compound or its derivatives. The method involves the use of the compound in combination with other therapeutic agents such as vancomycin, fidaxomicin, or metronidazole for enhanced efficacy. The patent highlights the potential of the compound in combating C. difficile infections and provides a detailed framework for its synthesis and pharmaceutical formulation.
To know more about GlobalData’s detailed insights on Recursion Pharmaceuticals, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies
